(Q30451302)

15 September 2017

Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis (English)

1 reference

15 September 2017

Pseudomonas aeruginosa

0 references

1 reference

R W Strunk

1

1 reference

15 September 2017

J C Gratz

series ordinal

2

1 reference

15 September 2017

R Maserati

series ordinal

3

1 reference

15 September 2017

W M Scheld

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1985

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

3

1 reference

15 September 2017

428-432

1 reference

Clindamycin therapy of experimental Staphylococcus aureus endocarditis

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Carbenicillin and ticarcillin.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Pharmacokinetics and tissue penetration of ciprofloxacin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

In vitro activity of ciprofloxacin (Bay o 9867)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Penicillin-Aminoglycoside Synergy in Experimental Streptococcus viridans Endocarditis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Pseudomonas aeruginosa endocarditis. Report of a case, with review of the literature

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Development of a statewide program for surveillance and reporting of hospital-acquired infections

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180267

Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model

26 November 2018

1 reference

12 December 2020

Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin

1 reference

12 December 2020

Experimental animal endocarditis

1 reference

12 December 2020

Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa

1 reference

12 December 2020

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

12 December 2020

Evaluation of azlocillin in vitro and in discriminative animal models of infection

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.28.3.428

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

2934021

1 reference